Gilead Sciences Archives | RaynbowAffair

All posts tagged "Gilead Sciences"

FDA Approves First-In-Class HIV Treatment Option
By DiamondKesawn on January 3, 2023
Gilead Sciences, Inc. (Nasdaq: GILD) recently announced that Sunlenca® (lenacapavir), in combination with other antiretroviral(s) (ARV), has been granted approval by the U.S. Food and Drug...
Gilead Introduces the “COMPASS” Initiative
By DiamondKesawn on February 25, 2021
As the global community grapples with the COVID-19 crisis, the spotlight on the pervasiveness of health inequities in the U.S. has only been magnified. Whether...